Back to search

Article

Activating NRF2E79Q mutation alters the differentiation of human non-small cell lung cancer

2025-05-15

Abstract excerpt

<title>Abstract</title> <p>The NRF2 signaling pathway promotes tumor initiation, progression and resistance to chemotherapy, radiation therapy and immune checkpoint inhibitors. The mechanisms underlying the biology of NRF2-active tumors are varied, and include altered cellular metabolism, a reductive shift in redox state, and immunosuppression. Here we determined the molecular and phenotypic impact of NRF2 activa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c526243c-0b61-5406-a3e9-9c9c85b3ac4c
DOI
10.21203/rs.3.rs-6606334/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Activating NRF2E79Q mutation alters the differentiation of human non-small cell lung cancerDOI 10.21203/rs.3.rs-6606334/v1
Select a neighboring publication to make it the new centre.